ContraFect Corp Stock Nasdaq
Equities
US2123262014
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 03 | North American Morning Briefing : Apple, Amgen -2- | DJ |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.19M |
---|---|---|---|---|---|
Net income 2021 | -20M | Net income 2022 | -65M | EV / Sales 2021 | - |
Net cash position 2021 | 51.02M | Net cash position 2022 | 10.8M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.77
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |